ALPN
Nuveen Asset Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-513,175
| Closed | -$20.3M | – | 3461 |
|
|
2024
Q1 | $20.3M | Buy |
513,175
+383,209
| +295% | +$15.2M | 0.01% | 1166 |
|
|
2023
Q4 | $2.48M | Buy |
129,966
+36,581
| +39% | +$697K | ﹤0.01% | 2316 |
|
|
2023
Q3 | $1.07M | Sell |
93,385
-292
| -0.3% | -$3.34K | ﹤0.01% | 2548 |
|
|
2023
Q2 | $963K | Buy |
93,677
+61,948
| +195% | +$637K | ﹤0.01% | 2671 |
|
|
2023
Q1 | $245K | Hold |
31,729
| – | – | ﹤0.01% | 2952 |
|
|
2022
Q4 | $233K | Buy |
31,729
+3,047
| +11% | +$22.4K | ﹤0.01% | 3033 |
|
|
2022
Q3 | $207K | Buy |
28,682
+10,236
| +55% | +$73.9K | ﹤0.01% | 3108 |
|
|
2022
Q2 | $157K | Hold |
18,446
| – | – | ﹤0.01% | 3172 |
|
|
2022
Q1 | $160K | Hold |
18,446
| – | – | ﹤0.01% | 3217 |
|
|
2021
Q4 | $218K | Hold |
18,446
| – | – | ﹤0.01% | 3227 |
|
|
2021
Q3 | $184K | Hold |
18,446
| – | – | ﹤0.01% | 3281 |
|
|
2021
Q2 | $166K | Buy |
+18,446
| New | +$166K | ﹤0.01% | 3262 |
|